Related Experiment Video
Updated: Mar 12, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation
Rahul H Damani1, Jose I Suarez1
1From the Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, Houston, Texas.
Insights
Individuals with nonvalvular atrial fibrillation (NVAF) face a significant risk of secondary stroke. This review synthesizes current knowledge on NVAF stroke risk factors, diagnosis, and prevention strategies.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Stroke affects approximately 750,000 US adults annually, with a 3%-4% risk of secondary stroke after an initial event.
- Cardioembolic strokes constitute 20%-25% of all strokes, with nonvalvular atrial fibrillation (NVAF) being a primary source of embolism.
- NVAF accounts for up to half of all cardioembolic strokes, highlighting its critical role in stroke etiology.
Purpose of the Study:
- To present comprehensive information on stroke risk factors in patients with NVAF.
- To outline current approaches for risk stratification, diagnosis, and treatment of NVAF.
- To review secondary stroke prevention strategies and cost-effectiveness in the context of NVAF.
Main Methods:
- Literature review using PubMed search focused on secondary stroke prevention in NVAF.
- Analysis of findings from major clinical trials and established society guidelines.
- Inclusion of a cost-effectiveness analysis for stroke prevention in NVAF.
Main Results:
- Identification of key risk factors contributing to stroke in NVAF patients.
- Evaluation of diagnostic criteria and risk stratification tools for NVAF.
- Synthesis of evidence-based treatment and prevention guidelines for secondary stroke.
Conclusions:
- Effective management of NVAF is crucial for reducing the burden of secondary stroke.
- Risk stratification and timely intervention in NVAF can significantly improve patient outcomes.
- A comprehensive approach integrating risk assessment, diagnosis, and evidence-based prevention is essential for managing stroke risk in NVAF.
Abstract:
Approximately 750,000 US adults per year experience a stroke. On average, the annual risk for future ischemic stroke (secondary stroke) after an initial ischemic stroke or transient ischemic attack is approximately 3% to 4%. Cardioembolic strokes account for 20% to 25% of all strokes, with nonvalvular atrial fibrillation (NVAF) considered one of the main sources of embolism; this explains up to half of all cardioembolic strokes. We present the risk factors for stroke in NVAF, risk stratification, a diagnosis of NVAF, and treatment and prevention of stroke in NVAF. We reviewed the literature by performing a PubMed search of articles focusing on secondary stroke prevention in NVAF. This review examines the findings of major clinical trials and society guidelines for secondary stroke prevention in NVAF and presents a cost-effectiveness analysis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Atherosclerosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Dysrhythmias VI: Management of Dysrhythmias
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Mitral Stenosis III: Medical Management

